Effect of Fixture Thread Depth on Accuracy of Immediate Implant Placement Using Dynamic Navigation

Is the Accuracy of Immediate Implant Placement Using Dynamic Navigation Affected by Fixture Thread Depth?: A Randomized Controlled Trial

The goal of this clinical trial is to compare the placement accuracy in immediately placed implants using dynamic navigation between deep-threaded and regular-threaded implants in partially edentulous patients. The main question it aims to answer is: is there a difference in implant placement accuracy between deep-threaded and regular-threaded implants using dynamic navigation? Participants will receive implants placed immediately under dynamic guidance. Researchers will compare type of implant thread (Straumann BLT versus Straumann BLX) to see if there are significant differences in placement accuracy.

Study Overview

Status

Not yet recruiting

Detailed Description

The initial visit will comprise a thorough clinical examination and panoramic radiograph acquisition. Hopeless teeth resulting from trauma, periapical abscess, and periodontitis will be evaluated to see if extraction indications are met. When extraction indications were met, patients will be evaluated for suitable bone height for immediate implant placement. When bone height was suitable, patients will be asked to take a preoperative CBCT scan.

After tooth condition and bone volume evaluations, patients with adequate bone volume for immediate implant placement will be enrolled and randomly assigned to one of two groups: deep-threaded or regular-threaded.

The following implant placement accuracy parameters will be recorded using postoperative intraoral scanning superimposition: Global platform deviation (measured in millimeters), lateral platform deviation (measured in millimeters), global apex deviation (measured in millimeters), apex depth deviations (measured in millimeters), and angular deviation (measured in degrees). Primary implant stability will be measured immediately after implant insertion and measured in both insertion torque value and implant stability quotient. Radiographic bone-implant contact will be measured with a 3D implant model reconstruction method using coDiagnostiX and the contact area will be calculated using 3-matic Research as previously reported. Marginal bone loss will be measured using ImageJ with periapical radiographs taken 3 months and 1-year post-op. Implant survival will be monitored starting from the final prosthesis delivery onwards. Complications (biological, technical, and implant loss) will be recorded accordingly. Patient satisfaction will be documented with a Mandarin Chinese version of the Short Form Patient Satisfaction Questionnaire (PSQ-18) upon final prosthesis delivery.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hopeless teeth that require extraction
  • No systemic diseases
  • Smoking (<10 cigarettes/day)
  • Full-mouth bleeding and full-mouth plaque index lower than or equal to 25%
  • Fresh extraction sockets with at least 3 fully intact socket walls
  • At least 4 mm of bone beyond the root apex
  • Meets one of the following:
  • Single immediate placement site in the maxillary esthetic zone [15-25 (FDI classification)].
  • Two or more nonconsecutive immediate placement sites in the maxillary esthetic zone [15-25 (FDI classification)].
  • Two or more consecutive immediate placement sites in the maxillary esthetic zone [15-25 (FDI classification)].

Exclusion Criteria:

  • General medical (American Society of Anesthesiologists, ASA, class III or IV) and/or psychiatric contraindications
  • Pregnancy or nursing
  • Any interfering medication such as steroid therapy or bisphosphonate therapy
  • Alcohol or drug abuse
  • Heavy smoking (>10 cigarettes/day)
  • Radiation therapy to head or neck region within 5 years
  • Untreated periodontitis
  • Refuse to participate in this trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Deep-threaded implants
Straumann BLX implants
Implant system with a deep fixture thread depth.
Placebo Comparator: Regular-threaded implants
Straumann BLT implants
Implant system with a regular fixture thread depth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Placement accuracy measured as global platform deviation in millimeters and assessed by DCarer or coDiagnostiX
Time Frame: Postoperative (Day 1-5)
Sufficiently described in the Title
Postoperative (Day 1-5)
Placement accuracy measured as lateral platform deviation in millimeters and assessed by DCarer or coDiagnostiX
Time Frame: Postoperative (Day 1-5)
Sufficiently described in the Title
Postoperative (Day 1-5)
Placement accuracy measured as global apex deviation in millimeters and assessed by DCarer or coDiagnostiX
Time Frame: Postoperative (Day 1-5)
Sufficiently described in the Title
Postoperative (Day 1-5)
Placement accuracy measured as apex depth deviations in millimeters and assessed by DCarer or coDiagnostiX
Time Frame: Postoperative (Day 1-5)
Sufficiently described in the Title
Postoperative (Day 1-5)
Placement accuracy measured as angular deviation in degrees and assessed by DCarer or coDiagnostiX
Time Frame: Postoperative (Day 1-5)
Sufficiently described in the Title
Postoperative (Day 1-5)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of primary implant stability measured in insertion torque (ITV) using a Torq Control
Time Frame: Intraoperative (Day 0)
Sufficiently described in the Title
Intraoperative (Day 0)
Level of primary implant stability measured in implant stability quotient (ISQ) using an Osstell Beacon
Time Frame: Intraoperative (Day 0)
Sufficiently described in the Title
Intraoperative (Day 0)
Amount of radiographic bone-implant contact measured in millimeters using 3-matic Research
Time Frame: Postoperative (Day 1-5)
Sufficiently described in the Title
Postoperative (Day 1-5)
Amount of marginal bone loss measured in millimeters using periapical radiographs
Time Frame: Postoperative (1 year)
Sufficiently described in the Title
Postoperative (1 year)
Rate of implant survival measured in percentage
Time Frame: Postoperative (4 months & 1 year)
Sufficiently described in the Title
Postoperative (4 months & 1 year)
Number of participants with biological or technical complications
Time Frame: Postoperative (Up to 1 year)
Sufficiently described in the Title
Postoperative (Up to 1 year)
Level of patient satisfaction measured using the Short Form Patient Satisfaction Questionnaire
Time Frame: Postoperative (4 months & 1 year)
Minimum value: 18; Maximum value: 90; Higher scores mean a better outcome
Postoperative (4 months & 1 year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yiqun Wu, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 31, 2023

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

September 3, 2023

First Submitted That Met QC Criteria

September 20, 2023

First Posted (Actual)

September 28, 2023

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 20, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Loss

Clinical Trials on Straumann BLX implant

Subscribe